MedTrace Logo

Prospective Registry on Intravascular Lithotripsy

NCT06577038 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-08-29

No results posted yet for this study

Summary

multicenter, international, all-comers registry aims to provide insights in the current application of IVL technology in patients with calcified coronary lesions undergoing PCI using IVL technology.

Conditions

  • Calcific Coronary Arteriosclerosis

Interventions

DEVICE

PCI with use of IVL

Use of IVL for the treatment of calcific coronary artery lesions at operator's discretion

Sponsors & Collaborators

  • Shockwave Medical, Inc.

    collaborator INDUSTRY

  • Leiden University Medical Center

    lead OTHER

Principal Investigators

  • José M Montero Cabezas, MD PhD · Leiden University Medical Center

  • Ibtihal Al Amri, MD PhD · Leiden University Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2024-02-01
Completion
2029-05-01
FDA Device
Yes

Countries

  • Belgium
  • Greece
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06577038 on ClinicalTrials.gov